Steris (STE) Cash from Financing Activities (2018 - 2026)
Steris (STE) recorded quarterly Cash from Financing Activities of -$97.9 million in Q1 2026, little changed quarter-over-quarter from -$98.0 million in Q4 2025, and up 45.03% on a YoY basis from -$67.5 million in Q1 2025.
Steris (STE) Cash from Financing Activities (2018 - 2026) Analysis & Trends
Steris' Cash from Financing Activities history runs 9 years deep, the most recent figure standing at -$97.9 million for Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 45.03% year-over-year to -$97.9 million; the TTM figure through Mar 2026 stood at -$568.2 million (up 63.86% YoY), while the FY2026 annual figure was -$568.2 million, up 63.86% from the prior year.
- Cash from Financing Activities was -$97.9 million for Q1 2026 at Steris, roughly flat from -$98.0 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $470.2 million in Q3 2023 to a low of -$998.9 million in Q2 2024.
- Historically, Cash from Financing Activities has averaged -$176.4 million across 5 years, with a median of -$178.1 million in 2025.
- The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities soared 1146.13% in 2023, then plunged 367.57% in 2024.
- A 5-year view of Cash from Financing Activities shows it stood at -$120.4 million in 2022, then plunged by 64.43% to -$198.0 million in 2023, then declined by 8.29% to -$214.4 million in 2024, then surged by 54.29% to -$98.0 million in 2025, then rose by 0.1% to -$97.9 million in 2026.
- The last three Cash from Financing Activities figures came in at -$97.9 million (Q1 2026), -$98.0 million (Q4 2025), and -$159.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | -2.09 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -26.93 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | -25.00 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | -97.90 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | -369.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -97.90 Mn |
| Mar 31, 2026 | -97.90 Mn |
| Dec 31, 2025 | -98.00 Mn |
| Dec 31, 2025 | -98.00 Mn |
| Sep 30, 2025 | -159.20 Mn |
| Sep 30, 2025 | -159.20 Mn |
| Jun 30, 2025 | -213.10 Mn |
| Jun 30, 2025 | -213.10 Mn |
| Mar 31, 2025 | -178.10 Mn |
| Mar 31, 2025 | -178.10 Mn |
| Dec 31, 2024 | -214.40 Mn |
| Dec 31, 2024 | -214.40 Mn |
| Sep 30, 2024 | -181.00 Mn |
| Sep 30, 2024 | -181.00 Mn |
| Jun 30, 2024 | -998.90 Mn |
| Jun 30, 2024 | -998.90 Mn |
| Mar 31, 2024 | -143.78 Mn |
| Mar 31, 2024 | -143.78 Mn |
| Dec 31, 2023 | -197.99 Mn |
| Dec 31, 2023 | -197.99 Mn |